NASDAQ$HSTM
HealthStream Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Announced third quarter 2021 results, showing revenue increase but a decrease in operating and net income.
HealthStream reported a 5% increase in revenue to $64.1 million for Q3 2021, driven by growth in Workforce and Provider Solutions, despite a decline in legacy resuscitation revenues. However, operating income and net income decreased due to higher operating expenses and amortization.
- Revenues increased by 5% to $64.1 million compared to Q3 2020.
- Workforce Solutions segment revenues grew by 4% to $51.2 million.
- Provider Solutions segment revenues increased to $12.9 million, primarily due to subscription revenues.
- Operating income decreased by 43% to $1.8 million, and net income also decreased by 43% to $1.5 million.
Headline financials
Revenue & EPS history
HealthStream · Revenue · Quarterly
$64.1M
Revenue by segment
HealthStream · $3.1M total across 2 segments · Q3 2023
- Subscription Revenues$3.4M—109.7%
- Professional Services-$300K—-9.7%
Forward guidance
HealthStream updated its full year 2021 guidance, anticipating a strong finish to the year with record adjusted EBITDA.
Tailwinds
- Expected record adjusted EBITDA of between $51 million to $53 million.
- Revenue growth driven by sales and implementations of product suites.
- Progress made in sales and implementations of product suites like the American Red Cross, CredentialStream, and Jane.
- Growth from newly acquired scheduling businesses.
- Company anticipates integration costs and additional investments in sales, marketing, and product development in 2021 for recently acquired companies
Headwinds
- Financial guidance assumes that public health conditions associated with the pandemic and general economic conditions (including conditions impacting healthcare organizations) continue to improve over the course of the year
- COVID-19 vaccines continue to be successfully distributed and perform according to current expectations
- New variants of the virus, or other unknown variants, do not further impede recovery from the pandemic.
- Estimated deferred revenue write-downs of $4.0 million during 2021 related to recent acquisitions, which would result in corresponding reductions to net revenues and operating income during 2021.
- Company’s guidance reflects the Company’s assumptions regarding, among other things, the COVID-19 pandemic as noted below
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+0.4%
Avg return
Earnings day
-1.3%
Avg return
5 days after
-0.3%
Avg return
30 days after
49%
32 / 65 earnings
Positive
+22.1%
Q3 2014
Best reaction
-19.3%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -5.0% | -5.2% | +3.6% | |
| Q4 2025 | +5.7% | -0.0% | +0.0% | |
| Q3 2025 | +2.8% | -2.6% | -2.4% | |
| Q1 2025 | -19.3% | -16.2% | -14.9% | |
| Q4 2024 | +0.1% | +4.4% | -0.8% | |
| Q3 2024 | +4.3% | -1.8% | +8.5% | |
| Q2 2024 | -3.0% | -3.4% | -7.3% | |
| Q1 2024 | +6.3% | +3.1% | +9.8% | |
| Q4 2023 | -1.6% | -2.8% | -2.8% | |
| Q3 2023 | +13.6% | +11.0% | +16.0% | |
| Q2 2023 | -1.4% | -3.7% | -8.1% | |
| Q1 2023 | -6.9% | -9.5% | -12.3% | |
| Q4 2022 | +4.9% | +3.1% | +7.0% | |
| Q3 2022 | +4.6% | +11.3% | +14.3% | |
| Q2 2022 | +4.5% | +2.1% | -2.0% | |
| Q1 2022 | +2.2% | -1.6% | +4.4% | |
| Q4 2021 | -17.0% | -16.7% | -14.7% | |
| Q3 2021 | -8.8% | -6.0% | -10.9% | |
| Q2 2021 | +0.6% | -0.8% | +0.2% | |
| Q1 2021 | +9.2% | +8.0% | +18.4% | |
| Q4 2020 | +0.7% | +0.5% | -2.6% | |
| Q3 2020 | -9.4% | -14.2% | -9.3% | |
| Q2 2020 | +0.3% | +1.1% | -5.6% | |
| Q1 2020 | -3.4% | -9.7% | -4.1% | |
| Q4 2019 | +0.2% | +1.4% | -16.1% | |
| Q3 2019 | +6.3% | +7.0% | +4.4% | |
| Q2 2019 | -0.8% | +3.4% | +3.5% | |
| Q1 2019 | -4.8% | -3.0% | -5.0% | |
| Q4 2018 | +3.9% | +1.5% | +5.8% | |
| Q3 2018 | +1.8% | -5.3% | -15.2% | |
| Q2 2018 | -6.5% | -4.2% | +6.2% | |
| Q1 2018 | +4.8% | +9.7% | +17.3% | |
| Q4 2017 | +6.0% | +2.0% | +1.9% | |
| Q3 2017 | -0.3% | -2.7% | +2.6% | |
| Q2 2017 | -12.0% | -12.6% | -13.5% | |
| Q1 2017 | +17.3% | +17.3% | +18.2% | |
| Q4 2016 | +0.1% | +5.0% | -2.8% | |
| Q3 2016 | -9.5% | -15.6% | -2.3% | |
| Q2 2016 | -3.9% | -6.2% | +0.1% | |
| Q1 2016 | -0.8% | — | — | |
| Q4 2015 | +12.9% | — | — | |
| Q3 2015 | +10.8% | — | — | |
| Q2 2015 | -0.6% | — | — | |
| Q1 2015 | +12.1% | — | — | |
| Q4 2014 | -7.9% | — | — | |
| Q3 2014 | +22.1% | — | — | |
| Q2 2014 | +13.9% | — | — | |
| Q1 2014 | -5.7% | — | — | |
| Q4 2013 | -7.2% | — | — | |
| Q3 2013 | -4.5% | — | — | |
| Q2 2013 | +11.2% | — | — | |
| Q1 2013 | +16.9% | — | — | |
| Q4 2012 | -0.2% | — | — | |
| Q3 2012 | +1.9% | — | — | |
| Q2 2012 | -2.9% | — | — | |
| Q1 2011 | -2.1% | — | — | |
| Q1 2012 | +2.0% | — | — | |
| Q4 2009 | -5.1% | — | — | |
| Q4 2011 | -5.1% | — | — | |
| Q3 2010 | -5.8% | — | — | |
| Q3 2011 | -5.8% | — | — | |
| Q2 2011 | -4.4% | — | — | |
| Q2 2010 | -4.4% | — | — | |
| Q4 2010 | -4.4% | — | — | |
| Q1 2010 | +5.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro